OpenVSafe by OpenVAERS
Search V-safe

9MP-33590-60547

5 vaccinations 7 coded responses 46 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
212 / MD
Registered
2021-02-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-16
    Registered in v-safe
  2. 2021-02-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-16
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-02-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  6. 2021-02-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Rash, not including the immediate area around the injection site
    Adult check-in
  7. 2021-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-02-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-09
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-09
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  14. 2021-03-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain, Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Swollen, painful ancillary lymph nodes on same side as injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Swollen, painful auxiliary lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Still dealing with painful, swollen lymph nodes, but they are slowly improving
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Headache
    Free text: Lymph nodes are slowly resolving.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache
    Adult check-in
  19. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-03-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-07
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-09-25
    Dose 3 — Pfizer-BioNTech
  29. 2021-10-02
    Survey response — day 7, dose 3
    MedDRA: Headache, Reaction to previous exposure to any vaccine — Feeling: Good
    Free text: I am a week out from my third booster. I did have a nasty headache starting post-injection day 2-4. The third booster was not as impactful as the second shot.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-09
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-10-16
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-10-23
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-10-30
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-06
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-12-27
    Survey response — 3 months, dose 3
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Major flair up of GERD
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-12-27
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  37. 2021-12-28
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  38. 2022-03-26
    Survey response — 6 months, dose 3
    MedDRA: Labile blood pressure — Feeling: Fair
    Free text: Labile blood pressure.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-05-01
    Dose 4 — Pfizer-BioNTech
    Co-administered: Pneumonia
  40. 2022-05-12
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  41. 2022-05-15
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-05-22
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-05-29
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  44. 2022-06-05
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  45. 2022-06-14
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  46. 2022-10-10
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  47. 2022-10-30
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-10-30
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  49. 2022-10-31
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  50. 2022-11-07
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  51. 2022-11-14
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  52. 2022-11-21
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  53. 2023-01-09
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  54. 2023-04-10
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-16Pfizer-BioNTech
22021-03-09Pfizer-BioNTech
32021-09-25Pfizer-BioNTech No
42022-05-01Pfizer-BioNTech Pneumonia
52022-10-10Pfizer-BioNTech Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-10

Systemic reaction (other): Swollen, painful ancillary lymph nodes on same side as injection

2021-03-11

Systemic reaction (other): Swollen, painful auxiliary lymph nodes

2021-03-12

Systemic reaction (other): Still dealing with painful, swollen lymph nodes, but they are slowly improving

2021-03-13

Systemic reaction (other): Lymph nodes are slowly resolving.

Release 9 — day 7, dose 3

2021-10-02

Systemic reaction (other): I am a week out from my third booster. I did have a nasty headache starting post-injection day 2-4. The third booster was not as impactful as the second shot.

Release 10 — 3 months, dose 3

2021-12-27

Symptoms: Major flair up of GERD

Release 11 — 6 months, dose 3

2022-03-26

Symptoms: Labile blood pressure.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCondition aggravated · · ✓
SDLabile blood pressure · · ✓
SDPre-existing disease · · ✓
SROAxillary pain ✓ ✓ ✓
SROHeadache · · ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROReaction to previous exposure to any vaccine · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release